CANNASIGNAL™
LIVE DATA
🔍
SIGNAL
HEMP BAN: Federal intoxicating-hemp ban takes effect Dec 11, 2026 — consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress — 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) — rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 — license applications open Feb 1, 2027IL: SB 3222 omnibus signed — possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court — repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed — hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program — bipartisan opposition buildingHEMP BAN: Federal intoxicating-hemp ban takes effect Dec 11, 2026 — consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress — 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) — rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 — license applications open Feb 1, 2027IL: SB 3222 omnibus signed — possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court — repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed — hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program — bipartisan opposition building
NH HB1796Introducedas of 2025-12-17

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

Plain-English summary

What happened: A New Hampshire bill to allow psilocybin in approved clinical settings received a committee recommendation of Inexpedient to Legislate on an 11-7 vote, signaling likely defeat.

Why it matters: The adverse committee recommendation reduces the likelihood of a legal psilocybin treatment framework being established in New Hampshire in this session.

Affects: patients and clinical providers

LATEST ACTION: Majority Committee Report: Inexpedient to Legislate 01/28/2026 (Vote 11-7; Regular Calendar) House Calendar 10 P. 91
READ THE FULL BILL TEXT →
Follow New Hampshire cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digest
More New Hampshire cannabis bills
SB624Restricting access to certain hemp-derived products and establishing the offenses of criminal adulteration and distribution of adulterated controlled substances.PassedHB1809Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.In CommitteeSB461Relative to the definition of hemp.In CommitteeSB400Relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.In CommitteeHB186Relative to the legalization and regulation of cannabis and making appropriations therefor.In CommitteeSB651Relative to the legalization and regulation of cannabis and making appropriations therefor.IntroducedSB650Relative to use of cannabis products for therapeutic purposes by alternative treatment centers.IntroducedHB1446Providing that an individual's use of therapeutic cannabis shall not disqualify the individual from the purchase, ownership, or possession of a firearm.Introduced
ALL NEW HAMPSHIRECANNABIS LAWS & BILLS →

Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.